Out-of-pocket spending (OOPS) and financial toxicity survey for neuroendocrine tumor (NET) patients.

632Background: Incidence and prevalence of neuroendocrine tumors (NETs) are on the rise. However, with the increasing burden of the disease, there is a need to understand financial toxicity associa...